The 9th International RASopathies Symposium
Year: 2026
Type: article
Abstract: The RASopathies are a group of congenital disorders with overlapping clinical manifestations that are caused by pathogenic germline or early somatic variants that result in the hyperactivation of the RAS/mitogen-activated protein kinase (MAPK) signaling pathway. Given the heterogeneous clinical presentations of these disorders that involve abnormalities across multiple organ systems, multidisciplinary clinical management and progress in scientific research are essential for optimal patient diagnosis and care. The 9th International RASopathies Symposium, a biennial meeting, was organized by the patient advocacy group RASopathies Network and showcased recent discoveries, case studies, and advances in preclinical research. Participants, who included scientists, clinicians, industry representatives, patients, and family advocates, explored knowledge gaps, innovative clinical approaches, and lived experiences of individuals with a RASopathy. Sessions centered around organ systems were introduced with a patient perspective to highlight the burden of disease, continued with presentations from established and early-career investigators. Overall, the RASopathies Symposia serve as a catalyst for sustained community collaboration focused on enhancing patient health and accelerating the translation of discoveries into effective treatments.
DOI: 10.1002/ajmg.a.70121
Authors: Pau Castel, Lisa Schoyer, Beth Stronach, Raya Bogdanova, Anton M. Bennett, Jaishri Blakeley, Miriam Bornhorst, Tammy Bowers, Saskia M. Brachmann, Emma Burkitt‐Wright, Kathryn Chatfield, Alessandro De Luca, Khalil El‐Chammas, Abdul Elkadri, John E. Fortunato, Bruce D. Gelb, Anne Goriely, Karen Gripp, Kassidy Grover, Lindsay Homan, Kenneth A. Kern, Maija Kiuru, Charles (Chuck) Lawson, Yong‐Seok Lee, Frank McCormick, Gina Ney, Cristina Nuevo‐Tapioles, Sara Pardej, Elizabeth I. Pierpont, Julia Plank, Nancy Ratner, Katherine A. Rauen, J. Elliott Robinson, Les Rogers, Sarah E. Sheppard, Keir Shiels, David Stevenson, Dagmar Tiemens, Matthew Traylor, K. Nicole Weaver, Marielle Yohe, Tamar Green
Institutions: New York University, Stanford Medicine, Stanford University, Yale University, Johns Hopkins University, Johns Hopkins Medicine, Northwestern University, Lurie Children's Hospital, Novartis (Switzerland), Novartis Institutes for BioMedical Research, University of Manchester, Manchester University NHS Foundation Trust, University of Colorado Anschutz, Casa Sollievo della Sofferenza, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Medical College of Wisconsin, Icahn School of Medicine at Mount Sinai, University of Oxford, NIHR Oxford Biomedical Research Centre, MRC Weatherall Institute of Molecular Medicine, University of California San Diego, University of California Davis Medical Center, University of California, Davis, Seoul National University, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, National Institutes of Health, Division of Cancer Epidemiology and Genetics, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, University of Minnesota, Cardio-Facio-Cutaneous International, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Great Ormond Street Hospital, Radboud University Medical Center, Amalia Kinderziekenhuis, Radboud Institute for Health Sciences, National Cancer Institute, Center for Cancer Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,710
Funders: U.S. Department of Health and Human Services, Children's Tumor Foundation, Pfizer, Alexion Pharmaceuticals, BioMarin Pharmaceutical, Revolution Medicines, Springworks Therapeutics, European Commission, National Institutes of Health, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Child Health and Human Development, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Intramural Research Program
OpenAlex ID: W7136144665
